Liarsin injection 10ml
DESCRIPTION
Lyarsin (Lyarsin) is a homeopathic preparation for the correction of metabolic processes, prevention and treatment of inflammatory diseases of the gastrointestinal tract in animals. Dosage form: injection solution. In appearance, the drug is a colorless transparent liquid.
COMPOSITION
Liarsin as active ingredients contains a matrix tincture of plant origin and mineral components (in 1000 ml): Lycopodium clavatum O = D1 1 nl, Acidum arsenicosum O = D2 0.01 nl, Phosphorus D26 3 Ојl and excipients: sodium chloride - 9 g , water for injection up to 1000 ml.
PHARMACOLOGICAL PROPERTIES
Liarsin belongs to the combined homeopathic medicines. It has a regulatory effect on metabolic processes, restores disturbed functions of the gastrointestinal tract, stimulates the immune system associated with the gastrointestinal tract (mucous-associated intestinal lymphoid tissues).
According to the degree of effect on the body of the drug, Liarsin belongs to low-hazard substances (hazard class 4 according to GOST 12.1.007-76), does not have a local irritant and sensitizing effect.
DOSAGE AND APPLICATION
Liarsin is prescribed to cattle, horses, pigs, sheep, goats, minks, dogs and cats of all age groups to correct metabolic processes, as well as to treat and prevent diseases of the gastrointestinal tract (gastritis, gastroenteritis).
Liarsin is administered to animals intramuscularly or subcutaneously.
For the correction of metabolic processes and the prevention of gastrointestinal diseases 2-3 times, with an interval of 7-10 days between injections; with a therapeutic purpose 4-6 times, with an interval between injections of 24 - 48 hours.
A single dose of the drug per animal is: for horses - 10.0-15.0 ml; cattle - 5.0-10.0 ml; pigs - 2.5-5.0 ml; goats, sheep - 2.0-2.5 ml; foals, calves, piglets - 2.0-2.5 ml; large and medium-sized dogs - 2.0-4.0 ml; small-breed dogs, cats, puppies, minks - 0.5-2.0 ml.
SPECIAL INSTRUCTIONS
Overdose symptoms in animals have not been established.
The peculiarities of the action of the drug during its first use and cancellation were not revealed.
Avoid skipping the next dose of the drug, as this can lead to a decrease in effectiveness. If one dose is missed, the use of the drug should be resumed as soon as possible in the same dose and according to the same scheme. Further, the interval until the next injection of the drug does not change.
With increased individual sensitivity and the manifestation of allergic reactions, the use of the drug is discontinued and antihistamines, beta-adrenomimetics, corticosteroids or other symptomatic therapy are prescribed.
The use of Liarsin does not exclude the use of other drugs for etiotropic, pathogenetic and symptomatic therapy.
Animal products during and after the application of LiarsinВ® can be used without restrictions.
CONTRAINDICATIONS
Contraindication to the use of Liarsin is an individual intolerance to the components of the drug.
SIDE EFFECTS
When Liarsin is used in accordance with this instruction, side effects and complications, as a rule, are not noted.
SHELF LIFE AND STORAGE
Store the drug in the manufacturer's sealed packaging, separately from food and feed, in a dry place protected from direct sunlight, at a temperature from 0 В° C to 25 В° C.
The shelf life of the drug, subject to storage conditions in a sealed package, is 3 years from the date of production.
PACKAGING
Liarsin is produced in 10 ml packs in glass bottles of appropriate capacity, hermetically sealed with rubber stoppers, reinforced with aluminum caps. Vials of 10 ml are packed in individual cardboard boxes along with instructions for use.
Specifications
KolVUP
thirty
Manufacturer
Helvet
Temperature regime
from 0 to +25
Teaser
for the correction of metabolic processes, as well as for the treatment and prevention of diseases of the gastrointestinal tract (gastritis, gastroenteritis)